Inventor · disambiguated record
Lucy Lu
Also filed as: LU LUCY
18 granted patents·11 pending applications·68 citations·filing 2016–2022
92Inventor score
Files withREVOGENEX IRELAND LTD16IBM6SORRENTO THERAPEUTICS INC3FORTRESS BIOTECH INC2Revogenix Ireland Ltd1
Top patents by PatentIndex Score
29 records- 0197US9980900B2Intravenous administration of tramadolREVOGENEX IRELAND LTD·Filed 2017·Granted May 29, 2018·16 cites·16 claims
- 0297US9693949B1Intravenous administration of tramadolREVOGENEX IRELAND LTD·Filed 2016·Granted Jul 4, 2017·19 cites·6 claims
- 0395US9968551B2Intravenous administration of tramadolREVOGENEX IRELAND LTD·Filed 2017·Granted May 15, 2018·16 cites·21 claims
- 0493US10022321B2Intravenous administration of tramadolRevogenix Ireland Ltd·Filed 2017·Granted Jul 17, 2018·16 cites·20 claims
- 0577US10751279B2Intravenous administration of tramadolREVOGENEX IRELAND LTD·Filed 2019·Granted Aug 25, 2020·0 cites·15 claims
- 0677US10729645B2Intravenous administration of tramadolREVOGENEX IRELAND LTD·Filed 2019·Granted Aug 4, 2020·0 cites·19 claims
- 0774US10751277B2Intravenous administration of tramadolREVOGENEX IRELAND LTD·Filed 2018·Granted Aug 25, 2020·0 cites·15 claims
- 0874US10624842B2Intravenous administration of tramadolREVOGENEX IRELAND LTD·Filed 2018·Granted Apr 21, 2020·0 cites·15 claims
- 0974US2020383904A1Intravenous administration of tramadolREVOGENEX IRELAND LTD·Filed 2020·Application pending·0 cites
- 1074US2020337988A1Intravenous administration of tramadolREVOGENEX IRELAND LTD·Filed 2020·Application pending·0 cites
- 1173US10729644B2Intravenous administration of tramadolREVOGENEX IRELAND LTD·Filed 2019·Granted Aug 4, 2020·0 cites·19 claims
- 1272US10617635B2Intravenous administration of tramadolREVOGENEX IRELAND LTD·Filed 2019·Granted Apr 14, 2020·0 cites·18 claims
- 1371US10751278B2Intravenous administration of tramadolREVOGENEX IRELAND LTD·Filed 2018·Granted Aug 25, 2020·0 cites·15 claims
- 1471US10646433B2Intravenous administration of tramadolREVOGENEX IRELAND LTD·Filed 2018·Granted May 12, 2020·0 cites·15 claims
- 1571US2020214975A1Intravenous administration of tramadolREVOGENEX IRELAND LTD·Filed 2020·Application pending·0 cites
- 1670US2020383905A1Intravenous administration of tramadolREVOGENEX IRELAND LTD·Filed 2020·Application pending·0 cites
- 1766US11455561B2Alerting to model degradation based on distribution analysis using risk tolerance ratingsIBM·Filed 2019·Granted Sep 27, 2022·1 cites·21 claims
- 1865US10537521B2Intravenous administration of tramadolREVOGENEX IRELAND LTD·Filed 2018·Granted Jan 21, 2020·0 cites·20 claims
- 1961US11376263B2Cyproterone acetate compositions and uses thereofFORTRESS BIOTECH INC·Filed 2021·Granted Jul 5, 2022·0 cites·30 claims
- 2060US2025084163A1Antigen Binding Proteins That Bind ROR1SORRENTO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2157US2022313705A1Cyproterone acetate compositions and uses thereofFORTRESS BIOTECH INC·Filed 2022·Application pending·0 cites
- 2255US2023406907A1Neutralizing Antibodies that Bind the SARS-COV-2 S ProteinSORRENTO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2355US2023416343A1Neutralizing Antibodies that Bind the SARS-COV-2 S ProteinSORRENTO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2453US11256597B2Ensemble approach to alerting to model degradationIBM·Filed 2019·Granted Feb 22, 2022·0 cites·24 claims
- 2549US11556845B2System for identifying duplicate parties using entity resolutionIBM·Filed 2019·Granted Jan 17, 2023·0 cites·18 claims
- 2648US11544477B2System for identifying duplicate parties using entity resolutionIBM·Filed 2019·Granted Jan 3, 2023·0 cites·16 claims
- 2748US2025242012A1Gene delivery systemSYMVIVO CORP·Filed 2021·Application pending·0 cites
- 2845US2021150397A1Ensemble approach to alerting to model degradationIBM·Filed 2019·Application pending·0 cites
- 2945US2021150394A1Systems and methods for alerting to model degradation based on survival analysisIBM·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lucy Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →